One step purification process for no-carrier-added 64Cu produced using enriched nickel target
-
, , , , , , und
Abstract
Copper-64 has found many applications in positron emission tomography (PET). Its half-life allows to use it for dosimetric studies associated to copper-67 targeted radiotherapy in cancer treatment. The use of 64Ni(p,n)64Cu nuclear reaction is known to produce 64Cu in large amount and with a high specific activity. In this study, targets were obtained by electroplating onto a gold backing and a typical target irradiation uses 200ߙnA, 17ߙMeV protons during 30ߙmin. After irradiation, pure copper-64 is obtained using only one chromatographic column. Nickel-64 is removed in a first elution step and cobalt isotopes in a second one. The extraction yield for copper-64 is 9±23% and nickel and cobalt impurities are under the detection limit. A recovery process of nickel-64 has also been developed.
© by Oldenbourg Wissenschaftsverlag, Saint-Herblain Cedex, Germany
Artikel in diesem Heft
- Preface to WIPR 2010
- Development of novel positron emitters for medical applications: nuclear and radiochemical aspects
- One step purification process for no-carrier-added 64Cu produced using enriched nickel target
- Some experimental studies on 89Zr production
- Paving the way to personalized medicine: production of some theragnostic radionuclides at Brookhaven National Laboratory
- Development of PET molecular targeting agents with gallium-68
- Chemical and biological evaluation of scandium(III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
- Highly stable acyclic bifunctional chelator for 64Cu PET imaging
Artikel in diesem Heft
- Preface to WIPR 2010
- Development of novel positron emitters for medical applications: nuclear and radiochemical aspects
- One step purification process for no-carrier-added 64Cu produced using enriched nickel target
- Some experimental studies on 89Zr production
- Paving the way to personalized medicine: production of some theragnostic radionuclides at Brookhaven National Laboratory
- Development of PET molecular targeting agents with gallium-68
- Chemical and biological evaluation of scandium(III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
- Highly stable acyclic bifunctional chelator for 64Cu PET imaging